What depth and technique should be used for intralesional triamcinolone injection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Intralesional Triamcinolone Injection Technique and Depth

Inject triamcinolone acetonide into the dermis at the upper subcutis level (just beneath the dermis) using a 25-27 gauge needle, with volumes of 0.05-0.1 mL per injection site to produce blanching of the lesion and 1-2 mm of surrounding skin. 1, 2

Injection Depth and Anatomical Target

The corticosteroid must be injected just beneath the dermis in the upper subcutis 2, 3. This is critical because:

  • Dermal injection is essential for efficacy - subcutaneous injection would be innocuous but ineffective 4
  • Initial dermal injection may meet with resistance, which tends to decrease with subsequent sessions 4
  • Atrophy of subcutaneous fat occurs if injection is not properly given 5

Needle Selection and Technique

Needle Specifications

  • Use 25-27 gauge needles for intralesional injections 4
  • Smaller gauge needles (25G) are preferred for keloids and dense lesions 6
  • For systemic intramuscular injections, minimum 1½ inch needle length is required 5

Injection Technique

Step-by-step approach:

  1. Cleanse the lesion and surrounding skin (Betadine or soap and water) 4

  2. Approach at right angle initially, then infiltrate in a V-shaped pattern 4

  3. Inject under pressure as the needle is advanced 4

  4. Continue until blanching is seen - the entire lesion and 1-2 mm of surrounding normal-appearing skin must be infiltrated 4

  5. Volume per site: 0.05-0.1 mL injection produces a tuft of response about 0.5 cm in diameter 2, 3

Concentration and Dosing by Indication

For Acne (Nodular/Cystic)

  • Concentration: 10 mg/mL triamcinolone acetonide, may be diluted to 5 or 3.3 mg/mL with sterile normal saline 1
  • Volume: Determined by lesion size, 0.2-5 mL in up to 4-5 injection sites 4
  • Estimated dose: approximately 0.1 mL/cm² 4

For Alopecia Areata

  • Concentration: Hydrocortisone acetate 25 mg/mL or triamcinolone acetonide 5-10 mg/mL 2, 3
  • Volume: 0.05-0.1 mL per injection site 2, 3

For Infantile Hemangiomas

  • Use triamcinolone and/or betamethasone for focal, bulky lesions during proliferation 7
  • Reserved for relatively small, well-localized lesions where proliferation threatens anatomic landmarks

For Keloids/Hypertrophic Scars

  • Concentration: Triamcinolone acetonide 40 mg/mL 1

Critical Anatomic Contraindications

Do NOT inject in these locations due to vascular compromise risk:

  • Fingers
  • Nose
  • Ears
  • Eyelids
  • Near the lips 4

Special warning for upper eyelid: Rare reports of central retinal artery embolization exist, likely related to high injection pressures and/or volumes 7

Common Pitfalls and How to Avoid Them

Local Complications from Improper Technique

  • Atrophy, pigmentary changes, telangiectasias result from local overdose 1
  • Fat and/or dermal atrophy occurs with improper depth 7
  • Subcutaneous fat atrophy if injection not properly given into gluteal muscle for systemic use 5

Prevention Strategies

  • Use lower concentrations and volumes to minimize local adverse events 8
  • Ensure strict aseptic technique 5
  • Avoid injecting into tendon substance - inject into tendon sheath for tenosynovitis 5
  • For epicondylitis, infiltrate into area of greatest tenderness 5

Pain Management

The procedure is painful; local anesthesia should be given in advance (such as EMLA cream - lidocaine plus prilocaine) 4. Young children may need general anesthesia 4. The main limitation to multiple injections is patient discomfort 2, 3.

Systemic Absorption Considerations

  • Adrenal suppression can occur with large doses (>4 mg/kg) 7
  • Repeated injections can suppress the hypothalamic-pituitary-adrenal axis 1
  • For infantile hemangiomas, avoid doses >4 mg/kg to prevent adrenal suppression 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.